Vor Biopharma's estimated fair value is US$15.10 based on 2 Stage Free Cash Flow to Equity. Vor Biopharma is estimated to be 49% undervalued based on current share p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback